Jefferey Jaxen

The U.S. Food and Drug Administration (FDA) has green-lit another Pfizer Covid vaccine for children. This time around it’s an Emergency Use Authorization (EUA) for a Pfizer booster aimed at kids 5 to 11 years of age – to make up for the lack of coverage from the failed 2-dose regime okayed in October of 2021. 

In what has now become commonplace for the agency, the FDA can no longer be bothered to publicly discuss the science or data surrounding its vaccines receiving an EUA. Despite the FDA’s budget for Fiscal Year 2021 of $6.1 billion, they could only muster a one-page press release to dictate to Americans that a third shot will now be coming to a kid’s arm near you. 

So what is the gold standard science contained in that press release?